BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29200159)

  • 1. Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.
    Banerjee JS; Heyman M; Palomäki M; Lähteenmäki P; Arola M; Riikonen PV; Möttönen MI; Lönnqvist T; Taskinen MH; Harila-Saari AH
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e13-e18. PubMed ID: 29200159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
    Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
    Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
    Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
    J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
    Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
    Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study.
    Anastasopoulou S; Heyman M; Eriksson MA; Niinimäki R; Taskinen M; Mikkel S; Vaitkeviciene GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Ranta S; Harila-Saari A
    Eur J Paediatr Neurol; 2020 Jul; 27():72-77. PubMed ID: 32340855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia during remission induction chemotherapy: a single-center retrospective study.
    Lin W; Xie J; Zhang J; Cheng H; Cui H; Zhang Y; Wu Y; Yu J; Qi P; Fan J; Gao H; Wang F; Zhang R; Zheng H
    Minerva Pediatr (Torino); 2023 Dec; 75(6):808-816. PubMed ID: 31729207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndrome.
    Zama D; Gasperini P; Berger M; Petris M; De Pasquale MD; Cesaro S; Guerzoni ME; Mastrodicasa E; Savina F; Ziino O; Kiren V; Muggeo P; Mura RM; Melchionda F; Zanazzo GA;
    Eur J Haematol; 2018 Jan; 100(1):75-82. PubMed ID: 29032616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of ALL Developing Posterior Reversible Encephalopathy Secondary to Hyponatremia.
    Eroglu N; Bahadir A; Erduran E
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e476-e478. PubMed ID: 28338570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.
    Gaziev J; Marziali S; Paciaroni K; Isgrò A; Di Giuliano F; Rossi G; Marziali M; De Angelis G; Alfieri C; Ribersani M; Andreani M; Palmieri MG; Placidi F; Romigi A; Izzi F; Floris R; Mercuri NB
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1531-1540. PubMed ID: 28602890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
    Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
    Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy.
    Gupta A; Swaroop C; Rastogi R; Garg R; Bakhshi S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):351-8. PubMed ID: 18484481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior reversible encephalopathy syndrome in a postpartum woman with acute lymphoblastic leukaemia after intrathecal methotrexate.
    Mescher C; Slungaard A
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome after pediatric heart transplantation: Increased risk for children with preexisting Glenn/Fontan physiology.
    Eilers B; Albers E; Law Y; McMullan DM; Shaw D; Kemna M
    Pediatr Transplant; 2016 Jun; 20(4):552-8. PubMed ID: 27139146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
    Tsukamoto S; Takeuchi M; Kawajiri C; Tanaka S; Nagao Y; Sugita Y; Yamazaki A; Kawaguchi T; Muto T; Sakai S; Takeda Y; Ohwada C; Sakaida E; Shimizu N; Yokote K; Iseki T; Nakaseko C
    Int J Hematol; 2012 Feb; 95(2):204-8. PubMed ID: 22160836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale.
    Zou LP; Liu LY; Li H; Wang YY; Liu Y; Chen J; Hu LY; Liu MJ; Zhang MN; Lu Q; Ma SF
    BMC Neurol; 2019 Feb; 19(1):30. PubMed ID: 30791893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging Patterns and Outcome of Posterior Reversible Encephalopathy Syndrome During Childhood Cancer Treatment.
    Khan RB; Sadighi ZS; Zabrowski J; Gajjar A; Jeha S
    Pediatr Blood Cancer; 2016 Mar; 63(3):523-6. PubMed ID: 26469881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior reversible encephalopathy syndrome in children with cancer.
    Morris EB; Laningham FH; Sandlund JT; Khan RB
    Pediatr Blood Cancer; 2007 Feb; 48(2):152-9. PubMed ID: 16317748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia major.
    Li XY; Huang K; Zhou DH; Li Y; Xu HG; Weng WJ; Xu LH; Fang JP
    Clin Transplant; 2019 Jan; 33(1):e13459. PubMed ID: 30506735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management.
    Ghali MGZ; Davanzo J; Leo M; Rizk E
    Leuk Lymphoma; 2019 Oct; 60(10):2365-2372. PubMed ID: 31556774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome.
    Fukuyama T; Tanaka M; Nakazawa Y; Motoki N; Inaba Y; Higuchi T; Koike K
    Pediatr Transplant; 2011 Dec; 15(8):E169-73. PubMed ID: 20735807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.